Cost-Effective Feedstock Icon
Efficient conversion of crude glycerol , an inexpensive industrial byproduct, significantly reduces the raw material cost.
Propylene Glycol 1,2-PDOL is a widely used chemical in Solvents/Antifreeze applications e.g. food additives, cosmetics, de-icing fluids, resins. The primary challenge is that Chemical production from propylene oxide is petrochemical-based , relying on fossil fuels and often involving hazardous processes. This necessitates a shift to bio-based, sustainable production methods.
CD Biosynsis offers a dedicated bioconversion engineering platform for 1,2-PDOL production: Bioconversion: Use engineered E. coli or yeast to convert Glycerol into Propylene Glycol 1,2-PDOL. Utilizing glycerol, a cheap biodiesel byproduct, ensures cost-effectiveness. We maximize the biocatalytic efficiency by focusing on Enzyme Engineering: Directed evolution of Glycerol Dehydratase and Propanediol Dehydrogenase for high flux . Optimizing these two key enzymes is vital for overcoming the metabolic bottlenecks and achieving a high final product titer.
Get a QuoteThe transition to bio-based 1,2-PDOL production faces these key challenges:
A successful solution must combine high enzyme efficiency with robust host cell tolerance and minimal byproduct formation.
CD Biosynsis utilizes comprehensive bioconversion and enzyme engineering to optimize 1,2-PDOL production:
Microbial Glycerol Bioconversion
We engineer high-performance host organisms like E. coli or yeast to efficiently convert low-cost crude glycerol into 1,2-PDOL via the methylglyoxal pathway or an alternative route.
Key Enzyme Engineering
We use directed evolution or rational design to enhance the activity and stability of Glycerol Dehydratase and Propanediol Dehydrogenase , resolving key metabolic bottlenecks.
Competing Pathway Knockout
We utilize metabolic engineering techniques e.g. gene knockout to eliminate or downregulate competing pathways that lead to undesirable byproducts like 1,3-PDOL and ethanol, maximizing 1,2-PDOL yield.
High-Titer and Tolerance Engineering
We engineer the host cell's stress response and membrane transport systems to improve tolerance to high concentrations of 1,2-PDOL and its intermediates , enabling high final titers. [Image of High Conversion Efficiency Icon]
This systematic engineering approach ensures high yield, low cost, and robust production of bio-based Propylene Glycol.
Our 1,2-PDOL engineering service is dedicated to pursuing the following production goals:
Cost-Effective Feedstock Icon
Efficient conversion of crude glycerol , an inexpensive industrial byproduct, significantly reduces the raw material cost.
Replace Petrochemical Reliance Icon
Sustainable bioconversion offers a green alternative to the hazardous and non-renewable propylene oxide route. [Image of Cost Reduction Icon]
High Catalytic Flux and Yield Icon
Enzyme and pathway engineering ensures the highest possible conversion rate and product yield from glycerol.
Enhanced Strain Robustness Icon
Engineered hosts demonstrate high tolerance to 1,2-PDOL and fermentation inhibitors, supporting high-titer production.
Minimal Byproduct Formation Icon
Targeted knockout of competing pathways significantly improves product purity , reducing downstream costs.
We deliver an economically optimized and high-performing microbial cell factory for sustainable Propylene Glycol biosynthesis.
Our 1,2-PDOL strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a sustainable, high-titer Propylene Glycol supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is Glycerol Dehydratase a bottleneck in the 1,2-PDOL pathway?
Glycerol Dehydratase catalyzes a critical step, the conversion of glycerol to 3-hydroxypropionaldehyde or similar intermediate. This enzyme is often sensitive to oxygen and can be inactivated by its substrate or product . Moreover, it often requires a complex co-factor e.g. adenosylcobalamin, which adds complexity. Enhancing its activity and robustness via enzyme engineering is vital for high flux.
How does crude glycerol feedstock impact the economics?
Crude glycerol is a cheap, waste byproduct from biodiesel production. By successfully engineering microbes to utilize this low-cost feedstock instead of expensive sugar or petrochemicals, we significantly reduce the raw material cost , making the final bio-based 1,2-PDOL competitive with the petrochemical alternative.
What role does product toxicity play in final titer?
Like many organic solvents, 1,2-PDOL can damage cell membranes and inhibit metabolic processes when present at high concentrations. If the host strain cannot tolerate high product levels, fermentation must be stopped prematurely, resulting in a low final titer. Tolerance engineering is thus necessary to achieve the high product concentrations required for economic recovery.
How are competing pathways minimized?
Competing pathways e.g. the ones leading to 1,3-PDOL or ethanol synthesis consume the glycerol substrate, lowering the yield of 1,2-PDOL. We minimize these losses by targeted gene knockout of the key enzymes in those undesirable pathways, effectively rerouting the carbon flux exclusively toward the target 1,2-PDOL product.
What is the estimated project timeline?
A comprehensive project involving pathway transfer, enzyme directed evolution, and fermentation optimization typically requires 26-34 weeks for final strain delivery and validated high-titer bioconversion protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.